Related Experiment Video
Updated: Jun 10, 2026
12:01
Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
Sensitive and specific detection of α-synuclein in human plasma
R B Tinsley1, K Kotschet, D Modesto
1Florey Neuroscience Institutes, University of Melbourne, Melbourne, Victoria 3010, Australia. rogan.tinsley@florey.com.au
Journal of Neuroscience Research
|July 22, 2010
Summary
New assays can measure alpha-Synuclein (alphasyn) in human plasma, aiding Parkinson's disease research. This development aims to improve understanding of alphasyn's role in neurological disorders.
Area of Science:
- Neuroscience
- Biochemistry
- Assay Development
Background:
- Alpha-Synuclein (alphasyn) aggregation is linked to Parkinson's disease (PD).
- alphasyn is found in extracellular fluids like plasma, but quantification is challenging.
- Existing studies on plasma alphasyn levels in PD lack sensitivity and standardization.
Purpose of the Study:
- To develop a sensitive and specific Enzyme-Linked Immunosorbent Assay (ELISA) for quantifying alphasyn in human plasma.
- To create a novel, high-sensitivity antibody for improved alphasyn detection.
- To enable large-scale studies for validating plasma alphasyn as a potential Parkinson's disease biomarker.
Main Methods:
- Adaptation of a published ELISA protocol for human plasma.
- Development and utilization of a novel, highly sensitive alphasyn-specific antibody.
- Validation of assay specificity for alphasyn in various sample types, including plasma.
Main Results:
- Successful development of a new ELISA for quantifying human plasma alphasyn.
- Demonstrated high specificity and signal-to-noise ratio for alphasyn detection using both commercial and novel antibodies.
- Confirmed the assay's ability to detect alphasyn in plasma samples.
Conclusions:
- The developed ELISA assays are suitable for large cohort studies to investigate plasma alphasyn levels in Parkinson's disease.
- Plasma alphasyn measurement holds potential as a valuable biomarker for Parkinson's disease diagnosis.
- These assays will also facilitate basic research into alphasyn secretion and its physiological/pathological roles.
